Wall Street Firms Initiate Coverage With Buy Ratings for Key Stocks

Major investment banks including Goldman Sachs, Jefferies, and Stifel have initiated coverage on several publicly traded companies, assigning buy or outperform ratings. Analysts cite strong growth potential in Braveheart Bio’s cardiac treatments, Attovia’s dermatology pipeline, and Jtekt’s manufacturing outlook.